Clinical Trial Update: Remimazolam for Cataract Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update indicates a study of remimazolam for cataract surgery is currently recruiting, with cognitive impairment listed as a condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Cognitive Impairment

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cataract Surgery, Cognitive Impairment | Phase 4 | Status: RECRUITING